Literature DB >> 22692277

[MicroRNA profiles in fine needle biopsy of the thyroid].

S Ting1, S-Y Sheu-Grabellus, K Worm, K W Schmid.   

Abstract

MicroRNAs (miRNAs) are small (20-24 nucleotides), non-coding ribonucleid acids, which regulate gene expression on the post-transcriptional level, thus influencing physiological processes including cellular growth, differentiation and apoptosis. Several miRNAs (e. g. miRNAs 146b, 221 and 222) have been shown to be consistently over-expressed in papillary thyroid carcinoma. The present overview describes and discusses the utilization and problems of miRNA analysis in material from thyroid nodules obtained by fine needle biopsy. Particularly the analysis of defined sets of miRNAs should improve the diagnostic value of this procedure and contribute to a better management of patients with cold thyroid nodules.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22692277     DOI: 10.1007/s00292-012-1581-0

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  28 in total

1.  Prevalence of RET/PTC rearrangements in Hashimoto's thyroiditis and papillary thyroid carcinomas.

Authors:  Marina N Nikiforova; Christy M Caudill; Paul Biddinger; Yuri E Nikiforov
Journal:  Int J Surg Pathol       Date:  2002-01       Impact factor: 1.271

2.  [Epidemiology, pathophysiology, guideline-adjusted diagnostics, and treatment of thyroid nodules].

Authors:  Ralf Paschke; Kurt Werner Schmid; Roland Gärtner; Klaus Mann; Henning Dralle; Christian Reiners
Journal:  Med Klin (Munich)       Date:  2010-02-20

3.  MicroRNA profiling of sporadic and hereditary medullary thyroid cancer identifies predictors of nodal metastasis, prognosis, and potential therapeutic targets.

Authors:  Deepak Abraham; Nicole Jackson; Justin S Gundara; JingTing Zhao; Anthony J Gill; Leigh Delbridge; Bruce G Robinson; Stan B Sidhu
Journal:  Clin Cancer Res       Date:  2011-05-27       Impact factor: 12.531

4.  German Association of Endocrine Surgeons practice guidelines for the surgical treatment of benign thyroid disease.

Authors:  Thomas J Musholt; Thomas Clerici; Henning Dralle; Andreja Frilling; Peter E Goretzki; Michael M Hermann; Jochen Kussmann; Kerstin Lorenz; Christoph Nies; Jochen Schabram; Peter Schabram; Christian Scheuba; Dietmar Simon; Thomas Steinmüller; Arnold W Trupka; Robert A Wahl; Andreas Zielke; Andreas Bockisch; Wolfram Karges; Markus Luster; Kurt W Schmid
Journal:  Langenbecks Arch Surg       Date:  2011-03-22       Impact factor: 3.445

5.  American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules.

Authors:  Hossein Gharib; Enrico Papini; Roberto Valcavi; H Jack Baskin; Anna Crescenzi; Massimo E Dottorini; Daniel S Duick; Rinaldo Guglielmi; Carlos Robert Hamilton; Martha A Zeiger; Michele Zini
Journal:  Endocr Pract       Date:  2006 Jan-Feb       Impact factor: 3.443

6.  [Hyalinizing trabecular tumor of the thyroid. An overcautious designation of a benign thyroid tumour?].

Authors:  S Ting; C Puttinger; K W Schmid; S-Y Sheu-Grabellus
Journal:  Pathologe       Date:  2012-03       Impact factor: 1.011

7.  Absence of BRAF, NRAS, KRAS, HRAS mutations, and RET/PTC gene rearrangements distinguishes dominant nodules in Hashimoto thyroiditis from papillary thyroid carcinomas.

Authors:  Peter M Sadow; Michael C Heinrich; Christopher L Corless; Jonathan A Fletcher; Vânia Nosé
Journal:  Endocr Pathol       Date:  2010-06       Impact factor: 3.943

8.  Contribution of molecular testing to thyroid fine-needle aspiration cytology of "follicular lesion of undetermined significance/atypia of undetermined significance".

Authors:  N Paul Ohori; Marina N Nikiforova; Karen E Schoedel; Shane O LeBeau; Steven P Hodak; Raja R Seethala; Sally E Carty; Jennifer B Ogilvie; Linwah Yip; Yuri E Nikiforov
Journal:  Cancer Cytopathol       Date:  2010-02-25       Impact factor: 5.284

Review 9.  Molecular diagnostics and predictors in thyroid cancer.

Authors:  Marina N Nikiforova; Yuri E Nikiforov
Journal:  Thyroid       Date:  2009-12       Impact factor: 6.568

10.  Specific microRNAs are downregulated in human thyroid anaplastic carcinomas.

Authors:  R Visone; P Pallante; A Vecchione; R Cirombella; M Ferracin; A Ferraro; S Volinia; S Coluzzi; V Leone; E Borbone; C-G Liu; F Petrocca; G Troncone; G A Calin; A Scarpa; C Colato; G Tallini; M Santoro; C M Croce; A Fusco
Journal:  Oncogene       Date:  2007-06-11       Impact factor: 9.867

View more
  1 in total

Review 1.  [Clinical importance of thyroid gland cytology].

Authors:  S Ting; S Synoracki; A Bockisch; D Führer; K W Schmid
Journal:  Pathologe       Date:  2015-11       Impact factor: 1.011

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.